C83.70
Burkitt lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Burkitt lymphoma is a highly aggressive type of non-Hodgkin lymphoma that originates from B-cells, a type of white blood cell involved in producing antibodies. When the specific site of the lymphoma isn't identified, it's classified as 'unspecified site' under ICD-10 code C83.70. While it can appear in various parts of the body, this form of lymphoma is known for its rapid growth and need for urgent treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect B-cell growth and division Infection with the Epstein-Barr virus (EBV), particularly associated with endemic cases in Africa Immunodeficiency conditions such as HIV/AIDS Exposure to certain chemicals or toxins (though less common)
Key Symptoms: Swelling or a painless lump in the affected area Unexplained fever or night sweats Unintentional weight loss Fatigue or general feeling of weakness Abdominal pain or swelling if the abdomen is involved Difficulty breathing or cough if the chest is affected Skin or oral ulcers in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Burkitt lymphoma typically involves a combination of medical imaging, such as CT scans or PET scans, and laboratory tests including biopsies. The biopsy of the affected tissue helps confirm the presence of lymphoma cells and their type. Additional blood tests may be conducted to assess overall health and organ function. Imaging studies are used to determine the extent and spread of the disease, guiding treatment planning.
Treatment Protocols: Treatment options primarily include intensive chemotherapy protocols designed to target rapidly dividing lymphoma cells. In addition, targeted therapies and immunotherapy may be considered in some cases. Supportive care is also important to manage symptoms and side effects from treatment. Due to the aggressive nature of Burkitt lymphoma, prompt diagnosis and initiation of therapy are essential for the best possible outcome.
Clinical Advice & FAQs
Billing Guidance
Is C83.70 a billable ICD-10 code?
Yes, C83.70 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.70?
Clinical documentation must specify the nature of Burkitt lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference